cephalexinmonohydrate , 98% , 23325-78-2
CAS NO.:23325-78-2
Empirical Formula: C16H19N3O5S
Molecular Weight: 365.4
MDL number: MFCD00167148
EINECS: 629-748-1
Pack Size | Price | Stock | Quantity |
1g | RMB239.20 | In Stock |
|
5g | RMB433.60 | In Stock |
|
25g | RMB1071.20 | In Stock |
|
others | Enquire |
PRODUCT Properties
Melting point: | >161°C (dec.) |
refractive index | 154 ° (C=0.5, H2O) |
storage temp. | Keep in dark place,Sealed in dry,Room Temperature |
solubility | NH4OH 1 M: 50 mg/mL, clear, yellow |
form | solid |
color | White to Light Beige |
Water Solubility | 13.5g/L(25 ºC) |
Merck | 14,1974 |
BRN | 965503 |
Stability: | Unstable in Solution |
InChIKey | AVGYWQBCYZHHPN-KJTIIWGRSA-N |
CAS DataBase Reference | 23325-78-2(CAS DataBase Reference) |
Description and Uses
Cephalexin was first synthesized in 1967 by Glaxo Research Laboratories and first produced on an industrial scale by Eli Lilly & Co. in the same year. It is a deacetoxylated derivative of cephaloglycin that is not metabolized in vivo. When administered orally, it shows a much higher serum concentration and much lower tendency to induce diarrhea than cephaloglycin. Cephalexin has been used widely and is the most popular orally active antibiotic in the world for treatment of respiratory tract, urinary tract, surgical, ear and nose, and other infections caused by Staphylococcus, Streptococcus, Escherichia coli, Klebsiella, Enterobacter, and Proteus.
Semi-synthetic cephalosporin antibiotic.
Safety
Symbol(GHS) | GHS07 |
Signal word | Warning |
Hazard statements | H302-H315-H319-H335 |
Precautionary statements | P261-P305+P351+P338 |
Hazard Codes | Xn |
Risk Statements | 42/43 |
Safety Statements | 22-36/37-45-24/25 |
WGK Germany | 3 |
RTECS | XI0350000 |
HS Code | 29419052 |
Toxicity | LD50 in mice, rats (g/kg): 1.6-4.5, >5.0 orally; 0.4-1.3, >3.7 i.p. (Welles) |